CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study

Trial StartKimmtrakPositive
AI Analysis

Summary

Immunocore has achieved its enrollment target in a clinical study evaluating Kimmtrak for label expansion, indicating progress in broadening the drug's approved indications.

Clinical Trial Data

Importance:5/10
Sentiment:
0.50
clinical trialenrollmentlabel expansion
Related Companies

Read the original article

Published by yahoo_finance on September 15, 2026 3:22 PM

Read Original